{"id":"https://openalex.org/G618127320","display_name":"Starve and Kill: Engineered Antigens Targeting Nutrient Acquisition Pathways Essential for Gonococcal Infection and Disease","description":"Project Narrative Neisseria gonorrhoeae, the causative agent of the sexually transmitted disease, gonorrhea, is a prevalent human pathogen that is associated with high economic and morbidity burdens. Gonorrhea infections are not protective and, despite many years of research, no vaccine to prevent the infection is yet available. This project seeks to test metal-transporting, outer membrane proteins as vaccine antigens and to use antigenic diversity, strain prevalence and community acceptance data to model the efficacy of potential N. gonorrhoeae vaccines.","funder_award_id":"U19AI144182","funder":{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","doi":"https://doi.org/10.13039/100000060"},"funded_outputs":["https://openalex.org/W2761860903","https://openalex.org/W2885137196","https://openalex.org/W2917355774","https://openalex.org/W2945827842","https://openalex.org/W2964419323","https://openalex.org/W2980718559","https://openalex.org/W2999274357","https://openalex.org/W3009566681","https://openalex.org/W3028638172","https://openalex.org/W3107174771","https://openalex.org/W3126013216","https://openalex.org/W3137621775","https://openalex.org/W3164676328","https://openalex.org/W3194012182","https://openalex.org/W4200425716","https://openalex.org/W4210392940","https://openalex.org/W4213101828","https://openalex.org/W4214505754","https://openalex.org/W4223625416","https://openalex.org/W4283750778","https://openalex.org/W4285494816","https://openalex.org/W4296094085","https://openalex.org/W4307922513","https://openalex.org/W4382632212","https://openalex.org/W4385336580","https://openalex.org/W4393346423","https://openalex.org/W4393581432","https://openalex.org/W4399573014","https://openalex.org/W4406433902","https://openalex.org/W4409504763","https://openalex.org/W4417535607","https://openalex.org/W7148900108","https://openalex.org/W7202080123"],"funded_outputs_count":33,"parent_awards":[],"sub_awards":[{"display_name":"Core-002","funder":{"display_name":"National Institutes of Health","id":"https://openalex.org/F4320332161"},"relationship":"component","id":"https://openalex.org/G9000930627","asserted_by":"funder"},{"display_name":"Project-002","funder":{"display_name":"National Institutes of Health","id":"https://openalex.org/F4320332161"},"relationship":"component","id":"https://openalex.org/G9000943342","asserted_by":"funder"},{"display_name":"Immunology Core","funder":{"display_name":"National Institutes of Health","id":"https://openalex.org/F4320332161"},"relationship":"component","id":"https://openalex.org/G9000946091","asserted_by":"funder"},{"display_name":"Using gonococcal TonB-dependent transporters as vaccine antigens","funder":{"display_name":"National Institutes of Health","id":"https://openalex.org/F4320332161"},"relationship":"component","id":"https://openalex.org/G9000972649","asserted_by":"funder"},{"display_name":"ConProject-006","funder":{"display_name":"National Institutes of Health","id":"https://openalex.org/F4320332161"},"relationship":"component","id":"https://openalex.org/G9000978029","asserted_by":"funder"},{"display_name":"Administrative Core (Cornelissen)","funder":{"display_name":"National Institutes of Health","id":"https://openalex.org/F4320332161"},"relationship":"component","id":"https://openalex.org/G9000983937","asserted_by":"funder"},{"display_name":"Administrative Core","funder":{"display_name":"National Institutes of Health","id":"https://openalex.org/F4320332161"},"relationship":"component","id":"https://openalex.org/G9001004657","asserted_by":"funder"},{"display_name":"Understanding and optimizing the potential public health impact of a gonococcal vaccine","funder":{"display_name":"National Institutes of Health","id":"https://openalex.org/F4320332161"},"relationship":"component","id":"https://openalex.org/G9001023894","asserted_by":"funder"},{"display_name":"ConProject-005","funder":{"display_name":"National Institutes of Health","id":"https://openalex.org/F4320332161"},"relationship":"component","id":"https://openalex.org/G9001041877","asserted_by":"funder"},{"display_name":"Protein Core","funder":{"display_name":"National Institutes of Health","id":"https://openalex.org/F4320332161"},"relationship":"component","id":"https://openalex.org/G9001043034","asserted_by":"funder"},{"display_name":"Project 3: Understanding and optimizing the potential public health impact of a gonococcal vaccine","funder":{"display_name":"National Institutes of Health","id":"https://openalex.org/F4320332161"},"relationship":"component","id":"https://openalex.org/G9001069474","asserted_by":"funder"},{"display_name":"Protein Core","funder":{"display_name":"National Institutes of Health","id":"https://openalex.org/F4320332161"},"relationship":"component","id":"https://openalex.org/G9001113157","asserted_by":"funder"},{"display_name":"Immunology Core","funder":{"display_name":"National Institutes of Health","id":"https://openalex.org/F4320332161"},"relationship":"component","id":"https://openalex.org/G9001115898","asserted_by":"funder"},{"display_name":"Project-003","funder":{"display_name":"National Institutes of Health","id":"https://openalex.org/F4320332161"},"relationship":"component","id":"https://openalex.org/G9001118507","asserted_by":"funder"},{"display_name":"Project 2: Using gonococcal lactoferrin-binding proteins as vaccine antigens","funder":{"display_name":"National Institutes of Health","id":"https://openalex.org/F4320332161"},"relationship":"component","id":"https://openalex.org/G9001132236","asserted_by":"funder"},{"display_name":"Using gonococcal TonB-dependent transporters as vaccine antigens","funder":{"display_name":"National Institutes of Health","id":"https://openalex.org/F4320332161"},"relationship":"component","id":"https://openalex.org/G9001147638","asserted_by":"funder"},{"display_name":"Core-001","funder":{"display_name":"National Institutes of Health","id":"https://openalex.org/F4320332161"},"relationship":"component","id":"https://openalex.org/G9001157650","asserted_by":"funder"}],"sub_awards_count":17,"amount":null,"currency":"USD","amount_usd":null,"amount_usd_basis":null,"recipients":[],"recipient_countries":[],"recipient_regions":[],"research_scope":{"is_research":true,"basis":"funder_default","tier":1},"funding_type":"cooperative_agreement","funder_scheme":"U19","start_date":"2019-03-25","end_date":"2025-02-28","start_year":2019,"end_year":2025,"landing_page_url":"https://reporter.nih.gov/project-details/10355467","doi":null,"provenance":"nih_exporter","lead_investigator":{"given_name":"CYNTHIA N","family_name":"CORNELISSEN","orcid":null,"role_start":null,"affiliation":{"name":"GEORGIA STATE UNIVERSITY","country":"UNITED STATES","ids":null},"author":{"id":"https://openalex.org/A5075652025","display_name":"Cynthia Nau Cornelissen","orcid":"https://orcid.org/0000-0001-6294-6588"},"institutions":[{"id":"https://openalex.org/I181565077","display_name":"Georgia State University","ror":"https://ror.org/03qt6ba18","country_code":"US","type":"education","lineage":["https://openalex.org/I181565077"]}]},"co_lead_investigator":null,"investigators":null,"works_api_url":"https://api.openalex.org/works?filter=awards.id:G618127320","primary_topic":{"id":"https://openalex.org/T10873","display_name":"Bacterial Infections and Vaccines","score":0.9429,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10873","display_name":"Bacterial Infections and Vaccines","score":0.9429,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10428","display_name":"Reproductive tract infections research","score":0.051,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10120","display_name":"Bacterial Genetics and Biotechnology","score":0.001,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neisseria-gonorrhoeae","display_name":"Neisseria gonorrhoeae","score":1.0},{"id":"https://openalex.org/keywords/gonorrhea","display_name":"gonorrhea","score":0.974},{"id":"https://openalex.org/keywords/vaccine-antigens","display_name":"vaccine antigens","score":0.7},{"id":"https://openalex.org/keywords/antigenic-diversity","display_name":"antigenic diversity","score":0.958},{"id":"https://openalex.org/keywords/sexually-transmitted-infections","display_name":"sexually transmitted infections","score":0.777}],"sustainable_development_goals":[{"score":0.9789,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"institution_awarded":[{"id":"https://openalex.org/I181565077","display_name":"Georgia State University","ror":"https://ror.org/03qt6ba18","country_code":"US","type":"education","lineage":["https://openalex.org/I181565077"]}],"updated_date":"2026-11-13T03:01:57.000Z","created_date":"2026-10-09T19:56:01.000Z"}
